These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 15824032)
1. Sorbitan monopalmitate-based proniosomes for transdermal delivery of chlorpheniramine maleate. Varshosaz J; Pardakhty A; Baharanchi SM Drug Deliv; 2005; 12(2):75-82. PubMed ID: 15824032 [TBL] [Abstract][Full Text] [Related]
2. Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design. Aboelwafa AA; El-Setouhy DA; Elmeshad AN AAPS PharmSciTech; 2010 Dec; 11(4):1591-602. PubMed ID: 21063815 [TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of proniosomes containing lornoxicam. Madan JR; Ghuge NP; Dua K Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375 [TBL] [Abstract][Full Text] [Related]
4. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729 [TBL] [Abstract][Full Text] [Related]
5. Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability. Zidan AS; Mokhtar Ibrahim M; Megrab NAE Drug Dev Ind Pharm; 2017 Sep; 43(9):1450-1459. PubMed ID: 28420295 [TBL] [Abstract][Full Text] [Related]
6. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid. Wen MM; Farid RM; Kassem AA J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560 [TBL] [Abstract][Full Text] [Related]
7. A novel vesicular transdermal delivery of nifedipine - preparation, characterization and in vitro/in-vivo evaluation. Yasam VR; Jakki SL; Natarajan J; Venkatachalam S; Kuppusamy G; Sood S; Jain K Drug Deliv; 2016; 23(2):619-30. PubMed ID: 25005581 [TBL] [Abstract][Full Text] [Related]
8. Development and in vitro permeation studies of proniosomal based transdermal delivery system of Atenolol. Ramkanth S; Chetty CM; Sudhakar Y Pak J Pharm Sci; 2014 Jan; 27(1):115-20. PubMed ID: 24374439 [TBL] [Abstract][Full Text] [Related]
9. Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 2(3) factorial design and in vivo evaluation in rabbits. Soliman SM; Abdelmalak NS; El-Gazayerly ON; Abdelaziz N Drug Deliv; 2016 Jun; 23(5):1608-22. PubMed ID: 26758033 [TBL] [Abstract][Full Text] [Related]
10. Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats. Shah H; Nair AB; Shah J; Bharadia P; Al-Dhubiab BE Daru; 2019 Jun; 27(1):59-70. PubMed ID: 30701460 [TBL] [Abstract][Full Text] [Related]
11. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. El-Laithy HM; Shoukry O; Mahran LG Eur J Pharm Biopharm; 2011 Jan; 77(1):43-55. PubMed ID: 21056658 [TBL] [Abstract][Full Text] [Related]
12. Chlorpheniramine maleate containing chitosan-based nanoparticle-loaded thermosensitive in situ gel for management in allergic rhinitis. Kumar M; Upadhayay P; Shankar R; Joshi M; Bhatt S; Malik A Drug Deliv Transl Res; 2019 Dec; 9(6):1017-1026. PubMed ID: 31049842 [TBL] [Abstract][Full Text] [Related]
13. Transdermal delivery of oxybutynin chloride proniosomal gels for the treatment of overactive bladder. Rajabalaya R; David SR; Chellian J; Xin Yun G; Chakravarthi S Drug Deliv; 2016 Jun; 23(5):1578-87. PubMed ID: 26634274 [TBL] [Abstract][Full Text] [Related]
14. Proniosomes as a carrier system for transdermal delivery of tenoxicam. Ammar HO; Ghorab M; El-Nahhas SA; Higazy IM Int J Pharm; 2011 Feb; 405(1-2):142-52. PubMed ID: 21129461 [TBL] [Abstract][Full Text] [Related]
15. Design and evaluation of proniosomes as a carrier for ocular delivery of lomefloxacin HCl. Khalil RM; Abdelbary GA; Basha M; Awad GE; El-Hashemy HA J Liposome Res; 2017 Jun; 27(2):118-129. PubMed ID: 27079800 [TBL] [Abstract][Full Text] [Related]
16. Penetration enhancers in proniosomes as a new strategy for enhanced transdermal drug delivery. El Maghraby GM; Ahmed AA; Osman MA Saudi Pharm J; 2015 Jan; 23(1):67-74. PubMed ID: 25685045 [TBL] [Abstract][Full Text] [Related]
17. Transbuccal delivery of chlorpheniramine maleate from mucoadhesive buccal patches. Sekhar KC; Naidu KV; Vishnu YV; Gannu R; Kishan V; Rao YM Drug Deliv; 2008; 15(3):185-91. PubMed ID: 18379931 [TBL] [Abstract][Full Text] [Related]
18. In vitro characterization of a controlled-release chlorpheniramine maleate delivery system prepared by the air-suspension technique. Mathir ZM; Dangor CM; Govender T; Chetty DJ J Microencapsul; 1997; 14(6):743-51. PubMed ID: 9394255 [TBL] [Abstract][Full Text] [Related]
19. Proniosomes in transdermal drug delivery. Rahimpour Y; Kouhsoltani M; Hamishehkar H Curr Pharm Des; 2015; 21(20):2883-91. PubMed ID: 25925111 [TBL] [Abstract][Full Text] [Related]
20. Recent Developments in Proniosomal Transdermal Drug Delivery: An Overview. Sabale V; Charde M; Dumore N; Mahajan U Curr Drug Deliv; 2023; 20(6):683-693. PubMed ID: 35466874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]